Till the end of 2016, our department has treated 3311 patients with sequela of spinal cord injury, including 1522 patients with cervical cord injury, 1233 patients with thoracic cord injury (do not include T12-L1), 226?patients with both cervical cord and thoracic cord injury, and 330 patients with thoracic and lumbar cord injury (mainly T12-L1). We invented CT-guided intraspinal injection in 2006 and stem cell transplantation via endovascular intervention in 2011 to treat sequela of spinal cord injury, which apparently improved the treatment effect. Since 2011, the improvement rate of patients with sequela of spinal cord injury has reached 97%.
The improvement can be seen from:
1.Increase of muscle strength under the injured surface, better motor function than before.
2.Lower sensory level and enhance perception.
3.Abundance of atrophied muscles, increased limb muscle strength
4.Reduce spasm and abnormal high muscular tension.
5.Reduce neuropathic pain
6.A certain degree of improvement in dysdefecation and urinate disorder which were caused by sphincter disturbances, patients will have better bowls movement than before and can be aware of and control urinating.
7.Improvement in postural hypotension which was caused by damaged vegetative nerve function (especially for high-level spinal cord injury patients), and the body temperature is close to or back to normal.
8.More motor flexibility and abilities.


19 years old

2 years old

19 years old

About Us

The Stem Cell Department of General hospital of Chinese People’s Armed Police Forces is the first neural stem cell transplantation centre in China, which went through the World Health Organisation (WHO) clinical trial registration. The Hospital has also obtained the FDA clinical trial approval and had our laboratory certified with Good Manufacturing Procedures (GMP) certification of stem cell research and preparation. So far we have used stem cell therapy to treat 16,000+ patients from more than 30 countries.

Why choose us

Our department is the first nerve stem cell transplantation center in the country and abroad, which has passed through the WHO clinical registration test, received FDA approval of a clinical trial and was certified by the laboratory with the GMP standard of research. So far, we have already treated about 16,000+ patients from more than 30 countries with stem cell transplantation.

Contact us

Address: YongDing Road 69#, Haidian District, Beijing

Telephoe: +86 10 56259395

E-mail: cs1@thebrightdirection.com

Connect with us

Invalid Input

Invalid Input

Invalid Input